文献速递自身炎症与 IgG4 相关病

MEFV基因变异分类改进助力家族性地中海热治疗决策

Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究从INFEVERS数据库提取216个MEFV错义变异的REVEL评分,分析其与专家分类及 pyrin 功能域定位的相关性,发现REVEL评分与ISSAD共识分类良好相关,并计算出基因特异性阈值0.298,据此可重新分类96个变异,将意义不明变异比例从61.6%降至17.6%。

要点

  • REVEL评分与ISSAD专家共识分类良好相关,可辅助MEFV变异解读。
  • 基因特异性REVEL阈值0.298可将意义不明变异比例从61.6%降至17.6%。
  • 致病性变异在pyrin功能域上呈非随机分布,提示结构域定位有参考价值。

核心结论

  • 结合专家信息与敏感预测工具可更准确解读MEFV变异的临床后果,改善遗传咨询和患者管理。

研究设计与样本

  • 研究纳入INFEVERS数据库中216个MEFV错义变异,分为可能良性、意义不明、可能致病和未解决四类,计算REVEL评分分布、均值、置信区间及ROC曲线下面积。

主要发现

  • 致病性变异沿pyrin功能域呈非随机分布。
  • REVEL评分与ISSAD共识分类良好相关,并计算了不同截断值的灵敏度、特异度和准确度。
  • 基因特异性阈值0.298(含置信边界)可重新分类96个MEFV变异,使意义不明变异比例从61.6%降至17.6%。

关键数值与推荐

  • 基因特异性REVEL阈值0.298用于MEFV变异重新分类。
  • 重新分类96个变异后,意义不明变异比例从61.6%降至17.6%。

临床怎么用

  • 临床可参考REVEL评分及基因特异性阈值0.298辅助MEFV变异分类,减少意义不明变异,支持FMF诊断与治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: FMF is an inherited autoinflammatory syndrome caused by mutations in the MEFV gene. MEFV variants are still largely classified as acvariant of uncertain significance, or with unresolved classification, posing significant challenges in FMF diagnosis. Rare Exome Variant Ensemble Learner (REVEL) is a recently developed variant metapredictor tool. To reduce the number of MEFV variants with ambiguous classification, we extracted REVEL scores for all missense variants present in the INFEVERS database, and analysed its correlation with expert-based classification and localization in the MEFV-encoded pyrin functional domains. METHODS: The data set of 216 MEFV missense variants was divided into four categories (likely benign, variant of uncertain significance, likely pathogenic and unresolved). Variants were plotted onto the pyrin protein, the distribution of REVEL scores in each category was computed and means, confidence intervals, and area under the receiver operating curve were calculated. RESULTS: We observed a non-random distribution of pathogenic variants along the pyrin functional domains. The REVEL scores demonstrated a good correlation with the consensus classification of the International Study Group for Systemic Autoinflammatory Diseases. Sensitivity, specificity and accuracy were calculated for different cut-off values of REVEL scores and a gene-specific-threshold of 0.298 was computed with confidence boundary limits. This cut-off value allowed us to propose a reclassification of 96 MEFV gene variants, thus reducing the variant of uncertain significance proportion from 61.6% to 17.6%. CONCLUSION: The combination of available expert information with sensitive predictor tools could result in a more accurate interpretation of clinical consequences of MEFV gene variants, and to a better genetic counselling and patient management.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Accetturo M, D'Uggento AM, Portincasa P, et al. Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever. Rheumatology (Oxford). 2020. PMID: 31411330. doi:10.1093/rheumatology/kez332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。